[{"ID":"7042_15-2021_NCT04311385","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\n#3: Is the patient eligible for the clinical trial?\n\nPlease select one of the options in the bracket at the end of each question.\n\nThank you!","PROBA":0.9715290292},{"ID":"5264_12-2021_NCT00782327","TOPIC_YEAR":2021,"RESPONSE":"$}}%> \n\nPlease select one of the options in the bracket at the end of the evaluation.\n\nPlease provide your response.","PROBA":0.9186447285},{"ID":"33866_71-2021_NCT03907384","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9651370185},{"ID":"17266_36-2021_NCT03323788","TOPIC_YEAR":2021,"RESPONSE":"#1. Check if the patient's age is within the inclusion criteria.\n\n#2. Check if the patient's BMI is within the inclusion criteria.\n\n#3. Check if the patient has any of the exclusion criteria.\n\n#4. Check if the patient has any of the laboratory values within the inclusion criteria.\n\n#5. Check if the patient is taking any medications that are excluded from the study.\n\nPlease select one of the following options based on the patient's information:\n\nA. Eligible\nB. Excluded\nC. Irrelevant\n\nPlease select one of the following options based on the patient's information:\n\nA. Eligible\nB. Excluded\nC. Irrelevant","PROBA":0.9869821821},{"ID":"16873_36-2021_NCT00207233","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\n#3. Is the patient eligible for the clinical trial?\n\nPlease select one of the options in the bracket after each question.\n\nThank you!","PROBA":0.9837813265},{"ID":"6903_15-2021_NCT03043170","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\n#3. Is the patient eligible for the clinical trial?\n\nPlease select one of the options in the bracket at the end of each question.\n\nThank you!","PROBA":0.9916884123},{"ID":"5489_12-2021_NCT03868657","TOPIC_YEAR":2021,"RESPONSE":"#1. Check the inclusion criteria:\n\nThe patient is a healthy woman aged 34 years old, which meets the inclusion criteria of age \u226520 and \u226440 years.\n\n#2. Check the exclusion criteria:\n\nThe patient has a history of Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which may be considered a chronic disease and may exclude her from the study. However, the exclusion criteria do not mention Marfan's syndrome or mitral valve prolapse specifically. Therefore, we cannot definitively say that the patient is excluded based on these criteria.\n\n#3. Check the physical examination and laboratory test results:\n\nThe patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which may affect her metabolic and cardiovascular health. However, these conditions do not necessarily exclude her from the study, as the exclusion criteria only mention specific conditions such as chronic diseases.\n\n#4. Check the patient's current medications:\n\nThe patient is not taking any medications, which meets the inclusion criteria of no regular medication use.\n\nBased on the information provided, the patient is potentially eligible for the clinical trial, but the final decision would depend on the discretion of the study physician and the sponsor. Therefore, I would select option C: Irrelevant.","PROBA":0.9853117045},{"ID":"17302_36-2021_NCT03547453","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\n#2: Does the patient meet the exclusion criteria?\n\n#3: Is the patient eligible for the clinical trial?\n\nPlease select one of the options in the bracket at the end of each question.\n\nThank you!","PROBA":0.9900786123},{"ID":"30613_65-2021_NCT01559025","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\n[A] Eligible\n[B] Excluded\n[C] Irrelevant\n\nPlease select one of the options in the bracket:\n\n(Please select one of the options in the bracket:\n\n[A] Eligible\n[B] Excluded\n[C] Irrelevant)","PROBA":0.9658864785},{"ID":"35696_75-2021_NCT03799887","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, here are the patient's characteristics that are relevant to the clinical trial:\n\n1. Diagnosis: The patient has been diagnosed with Parkinson's disease, which is a condition that is included in the clinical trial's inclusion criteria.\n2. Severity of disease: The patient's disease is classified as mild, Hoehn-Yahr Stage I, which is consistent with the clinical trial's inclusion criteria of moderate to advanced severity of disease.\n3. Medical history: The patient has a history of hypertension and hypercholesterolemia, which are not exclusion criteria for the clinical trial.\n4. Current medication: The patient is taking Levodopa and Trihexyphenidyl, which are common medications for Parkinson's disease and are not exclusion criteria for the clinical trial.\n5. Ability to walk: The patient is able to walk with or without assistive devices, which is an inclusion criterion for the clinical trial.\n\nBased on the patient's note, the patient is eligible for the clinical trial. Therefore, the final summary is:\n\n{A: eligible}","PROBA":0.9892641892},{"ID":"35518_75-2021_NCT02125825","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9620846615},{"ID":"35721_75-2021_NCT03958175","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, here is the evaluation step by step:\n\n1. Inclusion Criteria:\nThe patient is a 55-year-old man with Parkinson's disease, which satisfies the inclusion criterion of having Parkinson's disease.\n2. Montreal Cognitive Assessment (MoCA) test:\nThe patient's MoCA test result is not provided in the patient note. Therefore, we cannot determine if the patient meets the inclusion criterion of having a MoCA test score > 20.\n3. Other inclusion criteria:\nThe patient does not have any other exclusion criteria mentioned in the patient note, such as supranuclear palsy, other neurological disease, ophthalmologic disease, nystagmus, or visual acuity < 0.6.\n\nBased on the information provided, the patient is:\n\n{%C%}\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant","PROBA":0.9819743287},{"ID":"17064_36-2021_NCT01736410","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have histologically or cytologically confirmed adenocarcinoma of the stomach and Gastric-esophageal junction?\n\n#2. Does the patient have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded) as more than or equals to 20 mm with conventional techniques or as more than or equals to 10 mm with spiral CT scan?\n\n#3. Is the patient without prior systemic treatment?\n\n#4. Does the patient have normal organ and marrow function?\n\n#5. Is the patient able to take orally?\n\n#6. Does the patient have left ventricular ejection fraction of at least 50% on MUGA or 2D-echocardiography done within 28 days before enrollment?\n\n#7. Is the patient willing to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation?\n\nPlease answer the questions in the order they appear, and select one of the options (A, B, or C) for each question. Based on your answers, I will determine if the patient is eligible for the clinical trial.","PROBA":0.991827344},{"ID":"6716_15-2021_NCT01476995","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have any of the inclusion criteria?\n\nYes, the patient has one of the inclusion criteria: pancreatic adenocarcinoma.\n\n#2. Does the patient have any of the exclusion criteria?\n\nYes, the patient has one of the exclusion criteria: pregnant women.\n\n#3. Is the patient eligible for the clinical trial?\n\nBased on the information provided, the patient is not eligible for the clinical trial because they are pregnant.\n\nTherefore, the final answer is: B: Excluded.","PROBA":0.9949067499},{"ID":"17438_36-2021_NCT04715113","TOPIC_YEAR":2021,"RESPONSE":"$}}%5B%20A%3A%20eligible%2C%20B%3A%20excluded%2C%20C%3A%20irrelevant%5D%7B%20A%20or%20B%20or%20C%20%7D%20%3E%20%5B%20A%3A%20eligible%2C%20B%3A%20excluded%2C%20C%3A%20irrelevant%5D%20%5C%20%3C%20summary%3E%20The%20patient%20is%20not%20eligible%20for%20the%20clinical%20trial%20because%20she%20has%20a%20BMI%20outside%20the%20range%20specified%20in%20the%20inclusion%20criteria.%20The%20patient's%20BMI%20is%2041.54%2C%20which%20is%20greater%20than%20the%20upper%20limit%20of%2030%20specified%20in%20the%20inclusion%20criteria.%20Therefore%2C%20the%20patient%20is%20excluded%20from%20the%20clinical%20trial.%3C%2Fsummary%3E\n\nPlease select one of the options in the bracket: {A: eligible, B: excluded, C: irrelevant}.","PROBA":0.9900779823},{"ID":"35820_75-2021_NCT04781842","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, here are the inclusion and exclusion criteria that are relevant to the patient's eligibility for the clinical trial:\n\nInclusion Criteria:\n\n* Diagnosis of Parkinson's disease\n\nExclusion Criteria:\n\n* Inability to walk without physical assistance\n\nNow, let's evaluate the patient's eligibility based on these criteria:\n\nThe patient has a diagnosis of Parkinson's disease, which meets the inclusion criterion. However, the patient's note does not mention any information about their ability to walk without physical assistance, which is an exclusion criterion. Therefore, based on the information provided, the patient is:\n\n{%A: eligible%}\n\nPlease let me know if you have any further questions or if there's anything else I can help with.","PROBA":0.9863844692},{"ID":"27614_40-2022_NCT01307007","TOPIC_YEAR":2022,"RESPONSE":"#1. Does the patient have heavy uterine bleeding?\n\n#2. Does the patient have iron deficiency anemia?\n\n#3. Is the patient willing to use an acceptable form of contraception?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.\n\nThank you!","PROBA":0.9757869813},{"ID":"6754_15-2021_NCT01784393","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the following options:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nThank you for your time and assistance.","PROBA":0.9640474559},{"ID":"17222_36-2021_NCT03043521","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Eligibility%3A%20%3B%20Exclusion%20Criteria%3A%20%3B%20Irrelevant%20Data%3A%20%3B%20Final%20Summary%3A%20%3B%20Please%20select%20one%20of%20the%20options%20in%20the%20bracket%20above%20based%20on%20the%20patient's%20note%20and%20the%20clinical%20trial's%20inclusion%20and%20exclusion%20criteria.%20Please%20select%20one%20of%20the%20options%20in%20the%20bracket%20above%20based%20on%20the%20patient's%20note%20and%20the%20clinical%20trial's%20inclusion%20and%20exclusion%20criteria.","PROBA":0.9792231802},{"ID":"35586_75-2021_NCT02814201","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, here are the points to consider for each inclusion and exclusion criterion:\n\nInclusion Criteria:\n\n1. MMSE > 20\/30: The patient's note does not mention the patient's MMSE score, so this criterion is not met.\n2. Parkinson's disease: The patient has been diagnosed with Parkinson's disease, so this criterion is met.\n3. Hoehn and Yahr stage 1, 2, or 3: The patient's Hoehn and Yahr stage is stage I, so this criterion is met.\n4. Brain MRI performed during follow-up: The patient's note does not mention whether a brain MRI has been performed, so this criterion is not met.\n5. French mother tongue: The patient's note does not mention the patient's language proficiency, so this criterion is not met.\n\nExclusion Criteria:\n\n1. Illiteracy, writing or reading difficulties: The patient's note does not mention any difficulties with reading or writing, so this criterion is not met.\n2. Visual perceptual auditory deficit or preventing reading, drawing, writing or understanding instructions: The patient's note does not mention any visual or auditory deficits, so this criterion is not met.\n3. Visual hallucinations: The patient's note does not mention any visual hallucinations, so this criterion is not met.\n4. Significant history of cognition (unbalanced thyroid dysfunction, ischemic heart disease or embolic unstable or symptomatic, progressive neoplasia, chronic alcoholism weaned or not): The patient's note does not mention any significant history of cognition, so this criterion is not met.\n5. Current or previous neurological diseases other than MH or MP: The patient's note does not mention any other neurological diseases, so this criterion is not met.\n6. Psychiatric disorders (depression unless treated): The patient's note does not mention any psychiatric disorders, so this criterion is not met.\n7. Inability to achieve an autonomous operation without technical assistance over a distance of 20 meters: The patient's note does not mention any difficulties with mobility or independence, so this criterion is not met.\n8. Inability to stand without technical assistance for 30 seconds: The patient's note does not mention any difficulties with standing or balance, so this criterion is not met.\n\nBased on the patient's note, the patient is not eligible for the clinical trial because they do not meet all of the inclusion criteria and meet some of the exclusion criteria. Therefore, the final summary is:\n\n{%A: excluded%}","PROBA":0.9964739375},{"ID":"6675_15-2021_NCT01120340","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9334079317},{"ID":"35693_75-2021_NCT03778021","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, here is my evaluation of the patient's eligibility for the clinical trial:\n\n1. Age: The patient is 55 years old, which is within the age range of 21-75 years required for inclusion in the clinical trial. Therefore, the patient meets the age inclusion criterion.\n2. Gender: The patient is a male, which is consistent with the gender inclusion criterion of the clinical trial.\n3. Disease severity: The patient has been diagnosed with mild Parkinson's disease, which is consistent with the Hoehn-Yahr Stage I inclusion criterion.\n4. Past medical history: The patient has a history of hypertension and hypercholesterolemia, which are not exclusion criteria for the clinical trial.\n5. Current medications: The patient is taking Levodopa and Trihexyphenidyl, which are not exclusion criteria for the clinical trial.\n6. Family member\/child dyads: The patient is a family member of a child who is eligible for the clinical trial, as the child is aged 8-12 years and attends an elementary school in Tsaile or Shiprock.\n7. School location: The patient's child attends an elementary school in Tsaile or Shiprock, which is within the geographic location inclusion criterion.\n8. Garden site checklist: The patient's child's school has access to water, which satisfies the garden site checklist inclusion criterion.\n\nBased on the above evaluation, the patient meets all the inclusion criteria and none of the exclusion criteria for the clinical trial. Therefore, I conclude that the patient is eligible for the clinical trial.\n\nFinal summary: {A: eligible}.","PROBA":0.9860437529},{"ID":"14025_30-2021_NCT01513928","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9906898979},{"ID":"27777_40-2022_NCT02515058","TOPIC_YEAR":2022,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\n#3. Is the patient eligible for the clinical trial?\n\nPlease select one of the options in the bracket at the end of each question.\n\nThank you!","PROBA":0.993291016},{"ID":"35577_75-2021_NCT02749565","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9796716716},{"ID":"30704_65-2021_NCT02069106","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have type 1 diabetes?\n\n#2. Does the patient have a history of cardiovascular or coronary heart disease?\n\n#3. Is the patient currently taking a statin medication?\n\n#4. Does the patient have a history of excessive alcohol use?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.","PROBA":0.9949246645},{"ID":"30904_65-2021_NCT03930433","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have hypertension?\n\n#2. Does the patient have vasospastic angina?\n\n#3. Is the patient between the ages of 20 and 80?\n\n#4. Is the patient available for outpatient treatment?\n\n#5. Has the patient voluntarily signed a written consent to participate in the clinical trial?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.\n\nPlease select one of the following options based on the patient's eligibility for the clinical trial:\n\nA. Eligible\nB. Excluded\nC. Irrelevant\n\nPlease select one of the following options based on the patient's eligibility for the clinical trial:\n\nA. Eligible\n\nThe patient is eligible for the clinical trial because they have hypertension and vasospastic angina, are between the ages of 20 and 80, are available for outpatient treatment, and have voluntarily signed a written consent to participate in the clinical trial.","PROBA":0.9931485676},{"ID":"27790_40-2022_NCT02606045","TOPIC_YEAR":2022,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\n[A: eligible, B: excluded, C: irrelevant]","PROBA":0.9741605398},{"ID":"33515_71-2021_NCT01041079","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9669542498},{"ID":"28028_40-2022_NCT04202016","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is eligible for the clinical trial. Here's a step-by-step breakdown of why:\n\n1. Gender: The patient is female, which matches the inclusion criterion of \"Females.\"\n2. Minimum age: The patient is 23 years old, which is within the minimum age range of 15-29 years.\n3. Maximum age: The patient is 23 years old, which is within the maximum age range of 29 years.\n4. Healthy volunteers: The patient is a healthy volunteer, as they do not have any systematic diseases that could affect bone and tooth movement, and they have no contraindication to avoid oral surgery.\n5. Facial type: The patient has an average or high facial type, which matches the inclusion criterion of \"Average or high facial type.\"\n6. Space requirement: The patient has a class II division I of moderate space requirement, which matches the inclusion criterion of \"Class II division I of moderate space requirement.\"\n7. Orthodontic appliance: The patient has the defined orthodontic appliance, slot size, prescription, and technique of space closure, which matches the inclusion criterion of \"Having the defined orthodontic appliance, slot size, prescription, and technique of space closure.\"\n8. No active periodontal diseases: The patient does not have active periodontal diseases, which matches the inclusion criterion of \"No active periodontal diseases as this effect the cytokines expression (stabilized prostaglandin (PG) health).\"\n9. Good oral hygiene: The patient has good oral hygiene, which matches the inclusion criterion of \"Good oral hygiene.\"\n\nTherefore, based on the patient's note, the patient is eligible for the clinical trial.\n\nOption A: Eligible.","PROBA":0.9948489723},{"ID":"35737_75-2021_NCT04076332","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, here is my evaluation of the patient's eligibility for the clinical trial:\n\n1. Inclusion Criteria:\n\t* The patient is 55 years old, which is within the age range of 20-80 years old.\n\t* The patient has obstructive sleep apnea, as confirmed by polysomnography with a moderate severity (AHI \u2265 15).\n\t* The patient can communicate in Chinese, which is a requirement for inclusion.\n\nTherefore, the patient meets all the inclusion criteria.\n\n2. Exclusion Criteria:\n\t* The patient does not have dementia, mental illness, or language difficulties, which are all exclusion criteria.\n\nThe patient is eligible for the clinical trial. Therefore, I select option A: eligible.","PROBA":0.9820140545},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, here are the points to consider for each inclusion criterion:\n\n1. Gender: Female (met)\n2. Weight stability: The patient has been weight-stable for more than one year (met)\n3. No history of regular exercise: The patient has not exercised regularly in the past three months (met)\n4. Non-smoker: The patient does not smoke (met)\n5. Age: The patient is between 45 and 65 years old (met)\n\nNow, let's consider the exclusion criteria:\n\n1. History of CVD: The patient does not have a history of cardiovascular disease (met)\n2. Other disorders: The patient does not have diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, or food allergies or intolerances (met)\n3. Thyroid abnormality: The patient's thyroid function is normal (met)\n4. Electrocardiograph abnormality: The patient's electrocardiograph is normal (met)\n5. History of anti-obesity medication or weight loss drugs or dietary supplementations for weight control: The patient has not used any weight loss medications or supplements (met)\n\nBased on the patient's note, the patient is eligible for the clinical trial. Therefore, the final summary is:\n\n{%A: eligible%}","PROBA":0.9856408987},{"ID":"14148_30-2021_NCT03096613","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\n[A: eligible, B: excluded, C: irrelevant]","PROBA":0.9919931871},{"ID":"17176_36-2021_NCT02686294","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's information, here are the criteria to be met for the patient to be eligible for the clinical trial:\n\n1. Gender: The patient is a male, which meets the inclusion criterion of the clinical trial.\n2. Age: The patient is between 19 and 45 years old, which meets the inclusion criterion.\n3. Body weight and BMI: The patient's body weight is 113 kg, and their BMI is 41.54, which meets the inclusion criterion of a BMI of 18-29 kg\/m2.\n4. Health status: The patient does not have any serious active cardiovascular, respiratory, hepatologic, renal, hematologic, gastrointestinal, immunologic, dermal, neurologic, or psychological disease, which meets the inclusion criterion.\n5. Laboratory test results: The patient's laboratory test results, including FBS, TG, Cholesterol, LDL, HDL, and liver function tests, are within normal limits, which meets the inclusion criterion.\n6. Medication use: The patient does not use any prescription medication within 14 days prior to study medication dosing, which meets the inclusion criterion.\n7. Other criteria: The patient does not have any history of disease that may affect the absorption, distribution, metabolism, excretion of the drug, and they do not have any clinically significant allergic disease or hypersensitivity reaction to bepotastine, which meets the inclusion criterion.\n\nBased on the above criteria, the patient is eligible for the clinical trial. Therefore, the final answer is:\n\n{%A%} Eligible.","PROBA":0.9894579326},{"ID":"6848_15-2021_NCT02580422","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have locally advanced, metastatic or recurrent pancreatic ductal adenocarcinoma (PDAC)?\n\n#2. Is the patient being treated and\/or followed at Indiana University Simon Cancer Center or Eskenazi Hospital?\n\n#3. Does the patient have an ECOG PS of 0-2 at the time of study enrollment?\n\n#4. Does the patient have a life expectancy of > 6 months?\n\n#5. Does the patient have adequate organ function as defined by the study's laboratory values?\n\n#6. Is the patient willing to sign informed consent and to perform pulmonary function tests (PFTs) and strain echocardiogram?\n\nPlease answer each question with either \"yes\" or \"no\" before proceeding to the next question.","PROBA":0.9896151849},{"ID":"35663_75-2021_NCT03562403","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nBased on the information provided, here is my evaluation of the patient's eligibility for the clinical trial:\n\n1. Inclusion Criteria:\n\t* The patient has a diagnosis of Parkinson's disease, which satisfies criterion 1.\n\t* The patient has a minimum disease duration of 5 years, which satisfies criterion 2.\n\t* The patient has idiopathic Parkinson's disease, which satisfies criterion 3.\n\t* The patient has intractable tremors, which satisfies criterion 4.\n\t* The patient does not have significant cognitive impairment, which satisfies criterion 5.\n2. Exclusion Criteria:\n\t* The patient does not have significant medical health problems, which satisfies criterion 1.\n\t* The patient does not have bleeding tendencies, which satisfies criterion 2.\n\nBased on the above evaluation, the patient is eligible for the clinical trial. Therefore, I select option A: eligible.","PROBA":0.9959597538},{"ID":"27596_40-2022_NCT01148420","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is a 23-year-old female who has prolonged oral bleeding after a tooth extraction, which is consistent with the inclusion criteria of the clinical trial. The patient also has heavy menstrual cycles each month, which is relevant to the study's focus on acute excessive vaginal bleeding. Additionally, the patient has no other medical problems and takes no medications, which meets the inclusion criteria of being non-pregnant and able to understand and follow instructions. Furthermore, the patient's vital signs are stable, and there is no evidence of severe anemia or medical conditions requiring transfusion, which are all inclusive criteria.\n\nHowever, the patient's history of heavy menstrual cycles and her mother and grandmother's history of excessive bleeding during menstrual periods may be considered as a risk factor for bleeding complications, which could lead to exclusion from the study. Nevertheless, this information is not explicitly stated as an exclusion criterion in the clinical trial.\n\nTherefore, based on the patient's note and the inclusion and exclusion criteria of the clinical trial, I would conclude that the patient is eligible for the clinical trial.\n\nFinal summary: {A: eligible}.","PROBA":0.9864510878},{"ID":"23649_33-2022_NCT04355455","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient has Marfan syndrome, which is a genetic disorder that affects the body's connective tissue. The patient is also working as a driver and is cooperative with his medical appointments.\n\nThe clinical trial is investigating the effects of citalopram, a selective serotonin reuptake inhibitor, on esophageal sensitivity. The exclusion criteria for the trial include a history of psychiatric disease or a positive first-degree psychiatric family history, pregnancy or lactation, concomitant administration of any centrally activating medication, significant co-morbidities, prior history of esophageal, gastric surgery or endoscopic anti-reflux procedure, and history of gastrointestinal disease.\n\nTo determine the patient's eligibility for the clinical trial, we need to evaluate whether the patient meets the inclusion criteria and whether the patient meets any of the exclusion criteria.\n\nBased on the patient's note, the patient is 20 years old, which meets the inclusion criterion of age between 18-60 years. The patient is also a healthy volunteer, which meets the inclusion criterion of accepting healthy volunteers. However, the patient has Marfan syndrome, which is a genetic disorder that affects the body's connective tissue. This may be considered a significant co-morbidity and could potentially exclude the patient from participating in the clinical trial.\n\nTherefore, based on the patient's note, the patient is not eligible for the clinical trial because of the presence of Marfan syndrome, which is a significant co-morbidity that may affect the patient's participation in the study.\n\nOption: B - Excluded","PROBA":0.994781076},{"ID":"17269_36-2021_NCT03335904","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket: {A: eligible, B: excluded, C: irrelevant}.","PROBA":0.9883434102},{"ID":"17274_36-2021_NCT03395067","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information, here is my evaluation:\n\n1. Inclusion Criteria: The patient is a female obese infertile patient (BMI \u2265 30 kg\/m2) prior to an IVF cycle, which meets the inclusion criteria.\n2. Exclusion Criteria: The patient does not have any of the exclusion criteria such as diabetes, Cushing syndrome, premature ovarian failure, uncontrolled thyroidal dysfunction, hepatic and\/or renal dysfunction, antiphospholipid syndrome, medical condition that contraindicates ovarian stimulation and\/or pregnancy, simultaneous practice of another strategy to lose weight, physical conditions limiting exercise training, or inability to understand Spanish language or give informed consent.\n3. Other Relevant Information: The patient is a high-school teacher, married for 5 years, and has no prior pregnancies. She does not smoke or use any drugs and is willing to try diets and exercise to lose weight. Her cardiac assessment is normal, and her joints and ROM are within normal limits.\n\nBased on the above evaluation, I conclude that the patient is eligible for the clinical trial. Therefore, my final summary is:\n\n{%A: eligible%}","PROBA":0.9902676581},{"ID":"16928_36-2021_NCT00593138","TOPIC_YEAR":2021,"RESPONSE":"# A: Eligible\n# B: Excluded\n# C: Irrelevant\n\nPlease select one of the options above based on your evaluation of the patient's information and the inclusion\/exclusion criteria provided.","PROBA":0.9793432087},{"ID":"35355_75-2021_NCT00627640","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Patient%20Eligibility:%20\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nPlease provide your answer.","PROBA":0.9616829343},{"ID":"6909_15-2021_NCT03142152","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a diagnosis of ischemic or non-ischemic cardiomyopathy?\n\n#2. Does the patient have symptomatic functional (secondary) mitral regurgitation?\n\n#3. Is the patient's NYHA class II, III, or IV?\n\n#4. Does the patient have a corrected BNP of > 300 pg\/ml or corrected NT-proBNP > 1500 pg\/ml?\n\n#5. Is the patient receiving guideline-directed heart failure medication?\n\n#6. Is the patient aged 18 years or older?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question. Once you have answered all questions, please provide your final answer (A, B, or C) based on the patient's eligibility for the clinical trial.","PROBA":0.9901392027},{"ID":"11635_17-2022_NCT01843582","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is experiencing slowly worsening vision in both eyes, which suggests that the patient may have a disease that affects the fundus photograph or visual field, thereby making the patient ineligible for the clinical trial. Therefore, the patient is excluded from the clinical trial.\n\nSo, the final answer is B: excluded.","PROBA":0.9542568694},{"ID":"27977_40-2022_NCT03834727","TOPIC_YEAR":2022,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket at the end of the evaluation:\n\n[A: eligible, B: excluded, C: irrelevant]","PROBA":0.9792878978},{"ID":"25205_53-2021_NCT02408679","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain. She is married and has 3 children. Her past medical and drug history are unremarkable. Her BMI is 23, BP: 120\/75, HR: 75\/min. Her laboratory study is remarkable for Vit D: 14ng\/ml and otherwise healthy. (Ca: 9.2mg\/dl, Phosphorus: 3.2mg\/dl, PTH: 28pg\/ml)\n\nBased on the clinical trial, the exclusion criteria are:\n\n* Subject with diagnosed osteoporosis, osteopenia or osteomalacia.\n* Subject with known disease that contributes in osteoporosis: Rheumatoid arthritis, Malabsorption syndrome, Inflammatory bowel disease, Hyperthyroidism, Hyperparathyroidism.\n* Subject with known hepatic impairment.\n* Subject with known liver impairment or with a history of renal transplantation.\n* Subject with history of cancer.\n* Subject with history of bariatric surgery.\n* Subject taking or having taken osteoporosis inducing treatment, or treatment with an effect on calcium and phosphorus metabolism during the 3 months prior the visit: Corticosteroids, Enzyme inducing anticonvulsants, Heparin.\n* Subject requiring vitamin D supplementation for a diagnosed pathology.\n* Pregnant or breastfeeding Female.\n* Subject with history of alcohol or drug abuse.\n* Participation to any other clinical trial simultaneously and\/or not having ended the exclusion period of another clinical trial.\n* Subject of legal age unable of giving consent.\n* Subject deprived of liberty by judicial or administrative decision.\n* Subject of legal age under legal protection.\n* Subject having received over 4500 Euros for clinical trial participation within the prior year including the indemnity for the present study.\n\nBased on the patient's note, the patient does not have any of the exclusion criteria. However, the patient does not meet the inclusion criteria of being a healthy volunteer, as she has non-specific bones and joints pain. Therefore, the patient is excluded from the clinical trial.\n\nOption A: Eligible\n\nOption B: Excluded\n\nOption C: Irrelevant","PROBA":0.9949830733},{"ID":"35763_75-2021_NCT04233125","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is a 55-year-old man who was recently diagnosed with Parkinson's disease. The patient's disease is ranked as mild, Hoehn-Yahr Stage I. The patient is complaining of slowness of movement and tremors. The patient's past medical history is significant for hypertension and hypercholesterolemia. The patient does not smoke or use any illicit drugs. The patient is an alert and cooperative man who does not have any signs of dementia.\n\nBased on the clinical trial, the trial is studying the effectiveness of core decompression with or without cement packing for osteonecrosis of the femoral head (ONFH). The trial is open to all genders and ages, with a minimum age of 14 years. Healthy volunteers are not allowed to participate in the trial.\n\nTo determine the patient's eligibility for the clinical trial, we need to compare the patient's information to the inclusion and exclusion criteria of the trial.\n\nInclusion Criteria:\n\n* Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging\n\nThe patient's note does not mention the patient's ONFH stage. However, based on the patient's symptoms of slowness of movement and tremors, it is likely that the patient has an early stage of ONFH. Therefore, the patient may be eligible for the trial based on the inclusion criteria.\n\nExclusion Criteria:\n\n* Pre-existing collapse, subchondral fracture or degenerative changes of the hip\n\nThe patient's note does not mention any pre-existing collapse, subchondral fracture, or degenerative changes of the hip. Therefore, the patient does not meet any of the exclusion criteria.\n\nIn conclusion, based on the patient's note and the clinical trial's inclusion and exclusion criteria, the patient is potentially eligible for the trial. Therefore, the final summary is:\n\n{%A: eligible%}","PROBA":0.9870360238},{"ID":"5246_12-2021_NCT00456963","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Marfan's syndrome?\n\n#2. Does the patient have severe mitral valve prolapse with regurgitation?\n\n#3. Is the patient symptomatic?\n\n#4. Does the patient have a history of gestational diabetes mellitus?\n\n#5. Does the patient have hypertension?\n\n#6. Does the patient have obesity?\n\n#7. Does the patient have a history of c-section?\n\n#8. Does the patient have a history of laser eye surgery?\n\n#9. Does the patient have a history of cataract surgery?\n\n#10. Does the patient have a history of foot surgery?\n\nPlease answer the questions with a \"yes\" or \"no\" to help determine the patient's eligibility for the clinical trial.","PROBA":0.9976224094},{"ID":"13945_30-2021_NCT00388297","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have subclinical hypothyroidism or hypothyroxinemia?\n\n#2: Is the patient pregnant?\n\n#3: Is the patient's gestational age between 8 weeks 0 days and 20 weeks 6 days?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.\n\nPlease select one of the following options based on the patient's eligibility for the clinical trial:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the following options based on the patient's eligibility for the clinical trial:\n\nA: Eligible\nB: Excluded\nC: Irrelevant","PROBA":0.9845138611},{"ID":"17160_36-2021_NCT02559479","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options below:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nPlease select one of the options above by typing the corresponding letter.","PROBA":0.9293168182}]
